These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1961559)

  • 1. [Hemodynamic evaluation and SvO2 of inotropic drugs in ICU].
    Mandolfino T; Pedullà E; Praticò C; David A; Guzzo L; Mura M; Siracusano L; Sinardi AU
    Minerva Anestesiol; 1991 Oct; 57(10):934-5. PubMed ID: 1961559
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of intravenous positive inotropic therapy on myocardial damage in patients with dilated cardiomyopathy.
    Albayrak F; Demircan S; Yazici M; Arslandağ M
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):69. PubMed ID: 18258539
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of inotropic agents in dilated cardiomyopathy].
    Gorb GD; Zhdaniuk IuI; Makovskaia TE; Tsybul'nik ZI
    Klin Med (Mosk); 1989 Jan; 67(1):87-90. PubMed ID: 2654468
    [No Abstract]   [Full Text] [Related]  

  • 4. [Congestive cardiomyopathy: basal hemodynamics and hemodynamics after various positive inotropic drugs administered singly or in combinations].
    Cappello C; Fusaro MT; Mattioli G
    Cardiologia; 1988 Dec; 33(12):1127-32. PubMed ID: 3076518
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute and sustained hemodynamic effects of a new inotropic agent TA-064 (Denopamine) in patients with refractory heart failure with special reference to dose-response effects].
    Matsumoto N; Ito N; Kawagoe Y; Matsumura K; Honda T; Horie T; Takahashi S; Kimata S; Hirosawa K
    Kokyu To Junkan; 1986 Oct; 34(10):1113-20. PubMed ID: 3797842
    [No Abstract]   [Full Text] [Related]  

  • 6. [Protocol-guide in clinical experimentation on inotropic drugs].
    Campolo L; Padrini R; Razzolini R; Klugmann S; Chioin R
    G Ital Cardiol; 1985 Jul; 15(7):695-9. PubMed ID: 4076703
    [No Abstract]   [Full Text] [Related]  

  • 7. Digoxin and mortality in idiopathic dilated cardiomyopathy.
    Fauchier L; Babuty D; Cosnay P; Fauchier JP
    Eur Heart J; 2000 May; 21(10):858-9. PubMed ID: 10781361
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic heart failure: effect and evaluation of therapy with positive inotropic substances].
    Thormann J; Kramer W; Dieterich HA
    Herz; 1990 Jun; 15(3):190-201. PubMed ID: 2198220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dilated cardiomyopathy as a first sign of nutritional vitamin D deficiency rickets in infancy.
    Abdullah M; Bigras JL; McCrindle BW
    Can J Cardiol; 1999 Jun; 15(6):699-701. PubMed ID: 10375722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of levosimendan as an inotropic agent in conjunction with passive containment surgery.
    Bredin F; Franco-Cereceda A
    Scand Cardiovasc J; 2007 Jun; 41(3):197-200. PubMed ID: 17487771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congestive cardiomyopathy: treatment advances. Endomyocardial biopsy, new inotropes, beta-blockade.
    Slack JD; Nasser WK
    Indiana Med; 1986 Feb; 79(2):168-71. PubMed ID: 2869082
    [No Abstract]   [Full Text] [Related]  

  • 12. [The treatment of dilated cardiomyopathy].
    Amosova EN
    Ter Arkh; 1994; 66(3):88-91. PubMed ID: 7911259
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiomyopathy III--medical treatment.
    Vine DL
    Kans Med; 1989 Apr; 90(4):119-20. PubMed ID: 2724754
    [No Abstract]   [Full Text] [Related]  

  • 14. [How to select newly-developed oral inotropic agents: an evaluation based on their effects on heart rate and arrhythmias].
    Fukuda K; Handa S; Ogawa S; Nakamura Y; Kawamura Y
    J Cardiol; 1990; 20(3):755-65. PubMed ID: 2151866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of normal ventricular function in patients with dilated cardiomyopathy: relevance of the etiology.
    Santangeli P; Marzo F; Macchione A; Bellocci F; Crea F; Pieroni M
    Am Heart J; 2008 Jul; 156(1):e3. PubMed ID: 18585487
    [No Abstract]   [Full Text] [Related]  

  • 16. [Peculiarities of cardiac failure treatment in diffuse myocarditis and dilated cardiomyopathy].
    Gurevich MA; Iankovskaia MO; Gordienko BV; Mravian SR; Grigor'eva NM
    Klin Med (Mosk); 1997; 75(1):48-50. PubMed ID: 9082062
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dilated cardiomyopathy in children].
    Kurabayashi M; Yamaoki K; Yazaki Y
    Ryoikibetsu Shokogun Shirizu; 1996; (14):111-4. PubMed ID: 9047810
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current aspects and perspectives of the therapy with inotropic agents].
    Gullo A; Berlot G; Silvestri L
    Minerva Anestesiol; 1992 Oct; 58(10):665-8. PubMed ID: 1461439
    [No Abstract]   [Full Text] [Related]  

  • 19. Anesthetic management of a patient with severe dilated cardiomyopathy and an automatic implantable cardioverter-defibrillator (AICD) during total gastrectomy.
    Takeuchi M; Iwasaki T; Oue T; Taga N; Toda Y; Oe K; Morita K
    J Anesth; 2005; 19(1):81-3. PubMed ID: 15674523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of dilated cardiomyopathies. Recent findings].
    Perret C
    Ann Cardiol Angeiol (Paris); 1986 Jun; 35(6):311-6. PubMed ID: 2877610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.